Delivery Order SPE2DB24D2205-SPE2DB26FDSNQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $110,199.71 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) under a firm fixed price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a delivery order valued at $77,327.57 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count packaging) on July 28, 2025. This competitively awarded, firm fixed-price delivery order, which is not subject to any set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gilenya 0.5 mg capsules (30-count units) with a ceiling value of $20,252.06. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gilenya 0.5 mg capsules (30-count) valued at $11,008.02 under a firm fixed price arrangement. The contract, which is not set-aside, is scheduled for completion by August 29, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $103,162.18 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,630.00 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (quantity: 30 units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $8,809.80, is for the supply of Gilenya 0.5 mg capsules and has a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Gilenya 0.5 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order, valued at $20,129.07, has a completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation. In addition to this specific award, Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $12,350.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of the 0.5 mg dosage of Gilenya, to be delivered to their location in Conshohocken, Pennsylvania between August 11-14, 2023. Amerisourcebergen will fulfill the order for the multiple sclerosis drug from their corporate office division. The delivery order was issued against an existing DLA medical supply vehicle and no subcontractors or...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSNQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $33,570.41 to AmerisourceBergen Drug Corp for the supply of Gilenya 0.5 mg capsules (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen's contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical supply needs across multiple therapeutic domains through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.6k | 10/20/25 |